Indofarma Tbk PT banner

Indofarma Tbk PT
IDX:INAF

Watchlist Manager
Indofarma Tbk PT Logo
Indofarma Tbk PT
IDX:INAF
Watchlist
Price: 126 IDR Market Closed
Market Cap: Rp390.5B

Bankruptcy Probability

Indofarma Tbk PT's probability of bankruptcy is hidden . The solvency score is hidden .

We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.

Bankruptcy Probability
HIDDEN
Show

Financial Position

Cash & ST Investments
+
3Y
-87%
5Y
+28%
10Y
+134%
Long-Term Investments
+
3Y
-8%
5Y
-35%
10Y
+2 639%
Debt
+
3Y
-36%
5Y
-33%
10Y
-28%

Solvency Ratios

Solvency Ratios Comparison
Indofarma Tbk PT Competitors

Country Company Market Cap D/E D/A Interest
Coverage
Altman
Z-Score
Quick
Ratio
Current
Ratio
Cash
Ratio
ID
Indofarma Tbk PT
IDX:INAF
390.5B IDR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
853.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
566.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
243.3B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
213.1B GBP
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
288B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.8B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
115.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found
Is Indofarma Tbk PT at risk of bankruptcy?

Indofarma Tbk PT's probability of bankruptcy is hidden .

The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Indofarma Tbk PT have?

As of the latest report, Indofarma Tbk PT has total debt of 309.4B IDR. This includes both short-term (94B IDR) and long-term (215.4B IDR) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett